Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on BioXcel Therapeutics is 40 — signals are mixed heading into the print. Underlying trend: 4 tracked signals showing mixed direction over the last 3 months.
BioXcel Therapeutics (BTAI) is trading at $0.93, down 21.8% over the last 3 months (from $1.19 three months ago).
Trends across the last 3 months — the run-up to BioXcel Therapeutics’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 0 | No 3-month baseline |
| LinkedIn headcount | 53 | ↓ -3.6% |
| Sentiment | 85% Bullish | → flat |
| Web traffic | 7,380 | ↑ +14.1% |
| Employee business outlook | 20% Negative | → flat |
Full daily-resolution trend charts on every signal are on the BTAI ticker page.
AltIndex stock alerts fire when alt-data on BTAI breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for BioXcel Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in